Skip to main content
Top
Published in: BMC Oral Health 1/2023

Open Access 01-12-2023 | Stem Cell Transplantation | Research

The salivary proteome in relation to oral mucositis in autologous hematopoietic stem cell transplantation recipients: a labelled and label-free proteomics approach

Authors: S. J. M. van Leeuwen, G. B. Proctor, A. Staes, A. M. G. A. Laheij, C. M. J. Potting, M. T. Brennan, I. von Bültzingslöwen, F. R. Rozema, M. D. Hazenberg, N. M. A. Blijlevens, J. E. Raber-Durlacher, M. C. D. N. J. M. Huysmans

Published in: BMC Oral Health | Issue 1/2023

Login to get access

Abstract

Background

Oral mucositis is a frequently seen complication in the first weeks after hematopoietic stem cell transplantation recipients which can severely affects patients quality of life. In this study, a labelled and label-free proteomics approach were used to identify differences between the salivary proteomes of autologous hematopoietic stem cell transplantation (ASCT) recipients developing ulcerative oral mucositis (ULC-OM; WHO score ≥ 2) or not (NON-OM).

Methods

In the TMT-labelled analysis we pooled saliva samples from 5 ULC-OM patients at each of 5 timepoints: baseline, 1, 2, 3 weeks and 3 months after ASCT and compared these with pooled samples from 5 NON-OM patients. For the label-free analysis we analyzed saliva samples from 9 ULC-OM and 10 NON-OM patients at 6 different timepoints (including 12 months after ASCT) with Data-Independent Acquisition (DIA). As spectral library, all samples were grouped (ULC-OM vs NON-OM) and analyzed with Data Dependent Analysis (DDA). PCA plots and a volcano plot were generated in RStudio and differently regulated proteins were analyzed using GO analysis with g:Profiler.

Results

A different clustering of ULC-OM pools was found at baseline, weeks 2 and 3 after ASCT with TMT-labelled analysis. Using label-free analysis, week 1–3 samples clustered distinctly from the other timepoints. Unique and up-regulated proteins in the NON-OM group (DDA analysis) were involved in immune system-related processes, while those proteins in the ULC-OM group were intracellular proteins indicating cell lysis.

Conclusions

The salivary proteome in ASCT recipients has a tissue protective or tissue-damage signature, that corresponded with the absence or presence of ulcerative oral mucositis, respectively.

Trial registration

The study is registered in the national trial register (NTR5760; automatically added to the International Clinical Trial Registry Platform).
Appendix
Available only for authorised users
Literature
1.
go back to reference Blijlevens N, Schwenkglenks M, Bacon P, D’Addio A, Einsele H, Maertens J, et al. Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy–European Blood and Marrow Transplantation Mucositis Advisory Group. J Clin Oncol. 2008;26(9):1519–25.CrossRefPubMed Blijlevens N, Schwenkglenks M, Bacon P, D’Addio A, Einsele H, Maertens J, et al. Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy–European Blood and Marrow Transplantation Mucositis Advisory Group. J Clin Oncol. 2008;26(9):1519–25.CrossRefPubMed
2.
go back to reference Sonis ST, Oster G, Fuchs H, Bellm L, Bradford WZ, Edelsberg J, et al. Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol. 2001;19(8):2201–5.CrossRefPubMed Sonis ST, Oster G, Fuchs H, Bellm L, Bradford WZ, Edelsberg J, et al. Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol. 2001;19(8):2201–5.CrossRefPubMed
3.
go back to reference Peterson DE, Cariello A. Mucosal damage: a major risk factor for severe complications after cytotoxic therapy. Semin Oncol. 2004;31(3 Suppl 8):35–44.CrossRefPubMed Peterson DE, Cariello A. Mucosal damage: a major risk factor for severe complications after cytotoxic therapy. Semin Oncol. 2004;31(3 Suppl 8):35–44.CrossRefPubMed
4.
go back to reference Sonis ST. Pathobiology of oral mucositis: novel insights and opportunities. J Support Oncol. 2007;5(9 Suppl 4):3–11.PubMed Sonis ST. Pathobiology of oral mucositis: novel insights and opportunities. J Support Oncol. 2007;5(9 Suppl 4):3–11.PubMed
5.
go back to reference Wardill HR, Sonis ST, Blijlevens NMA, Van Sebille YZA, Ciorba MA, Loeffen EAH, et al. Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). Prediction of mucositis risk secondary to cancer therapy: a systematic review of current evidence and call to action. Support Care Cancer. 2020;28(11):5059–73. https://doi.org/10.1007/s00520-020-05579-7. Epub 2020 Jun 26. Wardill HR, Sonis ST, Blijlevens NMA, Van Sebille YZA, Ciorba MA, Loeffen EAH, et al. Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). Prediction of mucositis risk secondary to cancer therapy: a systematic review of current evidence and call to action. Support Care Cancer. 2020;28(11):5059–73. https://​doi.​org/​10.​1007/​s00520-020-05579-7. Epub 2020 Jun 26.
6.
go back to reference Krasny L, Huang PH. Data-independent acquisition mass spectrometry (DIA-MS) for proteomic applications in oncology. Mol Omics. 2021;17(1):29–42.CrossRefPubMed Krasny L, Huang PH. Data-independent acquisition mass spectrometry (DIA-MS) for proteomic applications in oncology. Mol Omics. 2021;17(1):29–42.CrossRefPubMed
7.
go back to reference Pedersen AML, Sørensen CE, Proctor GB, Carpenter GH, Ekström J. Salivary secretion in health and disease. J Oral Rehabil. 2018;45(9):730–46.CrossRefPubMed Pedersen AML, Sørensen CE, Proctor GB, Carpenter GH, Ekström J. Salivary secretion in health and disease. J Oral Rehabil. 2018;45(9):730–46.CrossRefPubMed
10.
go back to reference Xiao H, Zhang Y, Kim Y, Kim S, Kim JJ, Kim KM, et al. Differential proteomic analysis of human saliva using tandem mass tags quantification for gastric cancer detection. Sci Rep. 2016;6:22165.CrossRefPubMedPubMedCentral Xiao H, Zhang Y, Kim Y, Kim S, Kim JJ, Kim KM, et al. Differential proteomic analysis of human saliva using tandem mass tags quantification for gastric cancer detection. Sci Rep. 2016;6:22165.CrossRefPubMedPubMedCentral
11.
go back to reference Grassl N, Kulak NA, Pichler G, Geyer PE, Jung J, Schubert S, et al. Ultra-deep and quantitative saliva proteome reveals dynamics of the oral microbiome. Genome Med. 2016;8(1):44.CrossRefPubMedPubMedCentral Grassl N, Kulak NA, Pichler G, Geyer PE, Jung J, Schubert S, et al. Ultra-deep and quantitative saliva proteome reveals dynamics of the oral microbiome. Genome Med. 2016;8(1):44.CrossRefPubMedPubMedCentral
12.
go back to reference Jehmlich N, Stegmaier P, Golatowski C, Salazar MG, Rischke C, Henke M, et al. Differences in the whole saliva baseline proteome profile associated with development of oral mucositis in head and neck cancer patients undergoing radiotherapy. J Proteomics. 2015;125:98–103.CrossRefPubMed Jehmlich N, Stegmaier P, Golatowski C, Salazar MG, Rischke C, Henke M, et al. Differences in the whole saliva baseline proteome profile associated with development of oral mucositis in head and neck cancer patients undergoing radiotherapy. J Proteomics. 2015;125:98–103.CrossRefPubMed
13.
go back to reference Brennan MT, Hasseus B, Hovan AJ, Raber-Durlacher JE, Blijlevens NM, Huysmans MC, et al. Impact of Oral Side Effects from Conditioning Therapy Before Hematopoietic Stem Cell Transplantation: Protocol for a Multicenter Study. JMIR Res Protocols. 2018;7(4): e103.CrossRef Brennan MT, Hasseus B, Hovan AJ, Raber-Durlacher JE, Blijlevens NM, Huysmans MC, et al. Impact of Oral Side Effects from Conditioning Therapy Before Hematopoietic Stem Cell Transplantation: Protocol for a Multicenter Study. JMIR Res Protocols. 2018;7(4): e103.CrossRef
14.
go back to reference Palmer MK. WHO Handbook for Reporting Results of Cancer Treatment. Br J Cancer. 1982;45(3):484–5. Palmer MK. WHO Handbook for Reporting Results of Cancer Treatment. Br J Cancer. 1982;45(3):484–5.
15.
go back to reference van Leeuwen SJM, Proctor GB, Laheij AMGA, Potting CMJ, Smits O, Bronkhorst EM, et al. Significant salivary changes in relation to oral mucositis following autologous hematopoietic stem cell transplantation. Bone Marrow Transplant. 2021. van Leeuwen SJM, Proctor GB, Laheij AMGA, Potting CMJ, Smits O, Bronkhorst EM, et al. Significant salivary changes in relation to oral mucositis following autologous hematopoietic stem cell transplantation. Bone Marrow Transplant. 2021.
16.
go back to reference Vizcaíno JA, Deutsch EW, Wang R, Csordas A, Reisinger F, Ríos D, et al. ProteomeXchange provides globally coordinated proteomics data submission and dissemination. Nat Biotechnol. 2014;32(3):223–6.CrossRefPubMedPubMedCentral Vizcaíno JA, Deutsch EW, Wang R, Csordas A, Reisinger F, Ríos D, et al. ProteomeXchange provides globally coordinated proteomics data submission and dissemination. Nat Biotechnol. 2014;32(3):223–6.CrossRefPubMedPubMedCentral
17.
go back to reference Perez-Riverol Y, Bai J, Bandla C, García-Seisdedos D, Hewapathirana S, Kamatchinathan S, et al. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 2022;50(D1):D543–52.CrossRefPubMed Perez-Riverol Y, Bai J, Bandla C, García-Seisdedos D, Hewapathirana S, Kamatchinathan S, et al. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 2022;50(D1):D543–52.CrossRefPubMed
18.
go back to reference Chambers MC, Maclean B, Burke R, Amodei D, Ruderman DL, Neumann S, et al. A cross-platform toolkit for mass spectrometry and proteomics. Nat Biotechnol. 2012;30(10):918.CrossRefPubMedPubMedCentral Chambers MC, Maclean B, Burke R, Amodei D, Ruderman DL, Neumann S, et al. A cross-platform toolkit for mass spectrometry and proteomics. Nat Biotechnol. 2012;30(10):918.CrossRefPubMedPubMedCentral
19.
go back to reference Vaudel M, Venne AS, Berven FS, Zahedi RP, Martens L, Barsnes H. Shedding light on black boxes in protein identification. Proteomics. 2014;14(9):1001–5.CrossRefPubMed Vaudel M, Venne AS, Berven FS, Zahedi RP, Martens L, Barsnes H. Shedding light on black boxes in protein identification. Proteomics. 2014;14(9):1001–5.CrossRefPubMed
20.
go back to reference Barsnes H, Vaudel M, Colaert N, Helsens K, Sickmann A, Berven FS, et al. compomics-utilities: an open-source Java library for computational proteomics. BMC Bioinformatics. 2011;12:70.CrossRefPubMedPubMedCentral Barsnes H, Vaudel M, Colaert N, Helsens K, Sickmann A, Berven FS, et al. compomics-utilities: an open-source Java library for computational proteomics. BMC Bioinformatics. 2011;12:70.CrossRefPubMedPubMedCentral
21.
go back to reference Barsnes H, Vaudel M. SearchGUI: a highly adaptable common interface for proteomics search and de novo engines. J Proteome Res. 2018;17(7):2552–5.CrossRefPubMed Barsnes H, Vaudel M. SearchGUI: a highly adaptable common interface for proteomics search and de novo engines. J Proteome Res. 2018;17(7):2552–5.CrossRefPubMed
22.
go back to reference Vaudel M, Burkhart JM, Zahedi RP, Oveland E, Berven FS, Sickmann A, et al. PeptideShaker enables reanalysis of MS-derived proteomics data sets. Nat Biotechnol. 2015;33(1):22.CrossRefPubMed Vaudel M, Burkhart JM, Zahedi RP, Oveland E, Berven FS, Sickmann A, et al. PeptideShaker enables reanalysis of MS-derived proteomics data sets. Nat Biotechnol. 2015;33(1):22.CrossRefPubMed
24.
go back to reference Croft D, Mundo AF, Haw R, Milacic M, Weiser J, Wu G, et al. The Reactome pathway knowledgebase. Nucleic Acids Res. 2014;42(D1):D472–7.CrossRefPubMed Croft D, Mundo AF, Haw R, Milacic M, Weiser J, Wu G, et al. The Reactome pathway knowledgebase. Nucleic Acids Res. 2014;42(D1):D472–7.CrossRefPubMed
25.
go back to reference Consortium U. UniProt: a hub for protein information. Nucleic Acids Res. 2015;43(D1):D204–12.CrossRef Consortium U. UniProt: a hub for protein information. Nucleic Acids Res. 2015;43(D1):D204–12.CrossRef
26.
go back to reference Raudvere U, Kolberg L, Kuzmin I, Arak T, Adler P, Peterson H, et al. g: Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update). Nucleic Acids Res. 2019;47(W1):W191–8.CrossRefPubMedPubMedCentral Raudvere U, Kolberg L, Kuzmin I, Arak T, Adler P, Peterson H, et al. g: Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update). Nucleic Acids Res. 2019;47(W1):W191–8.CrossRefPubMedPubMedCentral
27.
go back to reference Messana I, Inzitari R, Fanali C, Cabras T, Castagnola M. Facts and artifacts in proteomics of body fluids. What proteomics of saliva is telling us? J Sep Sci 2008;31(11):1948–63. Messana I, Inzitari R, Fanali C, Cabras T, Castagnola M. Facts and artifacts in proteomics of body fluids. What proteomics of saliva is telling us? J Sep Sci 2008;31(11):1948–63.
28.
go back to reference Bassim CW, Ambatipudi KS, Mays JW, Edwards DA, Swatkoski S, Fassil H, et al. Quantitative salivary proteomic differences in oral chronic graft-versus-host disease. J Clin Immunol. 2012;32(6):1390–9.CrossRefPubMedPubMedCentral Bassim CW, Ambatipudi KS, Mays JW, Edwards DA, Swatkoski S, Fassil H, et al. Quantitative salivary proteomic differences in oral chronic graft-versus-host disease. J Clin Immunol. 2012;32(6):1390–9.CrossRefPubMedPubMedCentral
29.
go back to reference Devic I, Shi M, Schubert MM, Lloid M, Izutsu KT, Pan C, et al. Proteomic analysis of saliva from patients with oral chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2014;20(7):1048–55.CrossRefPubMedPubMedCentral Devic I, Shi M, Schubert MM, Lloid M, Izutsu KT, Pan C, et al. Proteomic analysis of saliva from patients with oral chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2014;20(7):1048–55.CrossRefPubMedPubMedCentral
30.
go back to reference Keshishian H, Burgess MW, Specht H, Wallace L, Clauser KR, Gillette MA, et al. Quantitative, multiplexed workflow for deep analysis of human blood plasma and biomarker discovery by mass spectrometry. Nat Protoc. 2017;12(8):1683.CrossRefPubMedPubMedCentral Keshishian H, Burgess MW, Specht H, Wallace L, Clauser KR, Gillette MA, et al. Quantitative, multiplexed workflow for deep analysis of human blood plasma and biomarker discovery by mass spectrometry. Nat Protoc. 2017;12(8):1683.CrossRefPubMedPubMedCentral
31.
go back to reference Moulder R, Bhosale SD, Goodlett DR, Lahesmaa R. Analysis of the plasma proteome using iTRAQ and TMT-based Isobaric labeling. Mass Spectrom Rev. 2018;37(5):583–606.CrossRefPubMed Moulder R, Bhosale SD, Goodlett DR, Lahesmaa R. Analysis of the plasma proteome using iTRAQ and TMT-based Isobaric labeling. Mass Spectrom Rev. 2018;37(5):583–606.CrossRefPubMed
32.
go back to reference Reyes-Gibby CC, Melkonian SC, Wang J, Yu RK, Shelburne SA, Lu C, et al. Identifying novel genes and biological processes relevant to the development of cancer therapy-induced mucositis: An informative gene network analysis. PLoS ONE. 2017;12(7): e0180396.CrossRefPubMedPubMedCentral Reyes-Gibby CC, Melkonian SC, Wang J, Yu RK, Shelburne SA, Lu C, et al. Identifying novel genes and biological processes relevant to the development of cancer therapy-induced mucositis: An informative gene network analysis. PLoS ONE. 2017;12(7): e0180396.CrossRefPubMedPubMedCentral
33.
go back to reference Costa-da-Silva AC, Aure MH, Dodge J, Martin D, Dhamala S, Cho M, et al. Salivary ZG16B expression loss follows exocrine gland dysfunction related to oral chronic graft-versus-host disease. iScience. 2021;25(1):103592. Costa-da-Silva AC, Aure MH, Dodge J, Martin D, Dhamala S, Cho M, et al. Salivary ZG16B expression loss follows exocrine gland dysfunction related to oral chronic graft-versus-host disease. iScience. 2021;25(1):103592.
34.
go back to reference Laheij AM, Raber-Durlacher JE, Koppelmans RG, Huysmans M-CD, Potting C, van Leeuwen SJ, et al. Microbial changes in relation to oral mucositis in autologous hematopoietic stem cell transplantation recipients. Sci Rep. 2019;9(1):1–11. Laheij AM, Raber-Durlacher JE, Koppelmans RG, Huysmans M-CD, Potting C, van Leeuwen SJ, et al. Microbial changes in relation to oral mucositis in autologous hematopoietic stem cell transplantation recipients. Sci Rep. 2019;9(1):1–11.
35.
go back to reference Pedersen AML, Belstrøm D. The role of natural salivary defences in maintaining a healthy oral microbiota. J Dent. 2019;80:S3–12.CrossRef Pedersen AML, Belstrøm D. The role of natural salivary defences in maintaining a healthy oral microbiota. J Dent. 2019;80:S3–12.CrossRef
37.
go back to reference Liew PX, Kubes P. The neutrophil’s role during health and disease. Physiol Rev. 2019;99(2):1223–48.CrossRefPubMed Liew PX, Kubes P. The neutrophil’s role during health and disease. Physiol Rev. 2019;99(2):1223–48.CrossRefPubMed
38.
go back to reference Faurschou M, Borregaard N. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect. 2003;5(14):1317–27.CrossRefPubMed Faurschou M, Borregaard N. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect. 2003;5(14):1317–27.CrossRefPubMed
40.
go back to reference Paladini RD, Takahashi K, Bravo NS, Coulombe PA. Onset of re-epithelialization after skin injury correlates with a reorganization of keratin filaments in wound edge keratinocytes: defining a potential role for keratin 16. J Cell Biol. 1996;132(3):381–97.CrossRefPubMed Paladini RD, Takahashi K, Bravo NS, Coulombe PA. Onset of re-epithelialization after skin injury correlates with a reorganization of keratin filaments in wound edge keratinocytes: defining a potential role for keratin 16. J Cell Biol. 1996;132(3):381–97.CrossRefPubMed
42.
go back to reference Kudrimoti M, Curtis A, Azawi S, Worden F, Katz S, Adkins D, et al. Dusquetide: A novel innate defense regulator demonstrating a significant and consistent reduction in the duration of oral mucositis in preclinical data and a randomized, placebo-controlled phase 2a clinical study. J Biotechnol. 2016;239:115–25.CrossRefPubMed Kudrimoti M, Curtis A, Azawi S, Worden F, Katz S, Adkins D, et al. Dusquetide: A novel innate defense regulator demonstrating a significant and consistent reduction in the duration of oral mucositis in preclinical data and a randomized, placebo-controlled phase 2a clinical study. J Biotechnol. 2016;239:115–25.CrossRefPubMed
Metadata
Title
The salivary proteome in relation to oral mucositis in autologous hematopoietic stem cell transplantation recipients: a labelled and label-free proteomics approach
Authors
S. J. M. van Leeuwen
G. B. Proctor
A. Staes
A. M. G. A. Laheij
C. M. J. Potting
M. T. Brennan
I. von Bültzingslöwen
F. R. Rozema
M. D. Hazenberg
N. M. A. Blijlevens
J. E. Raber-Durlacher
M. C. D. N. J. M. Huysmans
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Oral Health / Issue 1/2023
Electronic ISSN: 1472-6831
DOI
https://doi.org/10.1186/s12903-023-03190-w

Other articles of this Issue 1/2023

BMC Oral Health 1/2023 Go to the issue